Sitafloxacin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sitafloxacin
Sitafloxacin.png
Clinical data
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C19H18ClF2N3O3
Molar mass 409.81
3D model (Jmol)
 NYesY (what is this?)  (verify)

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

See also[edit]

References[edit]

  1. ^ Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections.". Drugs Today (Barc). 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900. 

Further reading[edit]

External links[edit]